
The bibliometric analysis of pediatric bronchial asthma research from 2000 to 2024 highlights growing global interest, with the U.S. as a major contributor. Key authors, journals, and institutions were identified, and emerging topics include allergic inflammation, type 2 immunity, and biologics. Inhaled corticosteroids remain effective treatments. The findings emphasize the need for continued international collaboration to improve clinical outcomes and understand pediatric asthma’s immunological mechanisms.
Like
Save
Share